A6657 - Posterior Reversible Encephalopathy Syndrome After 5-Fluorouracil Therapy for Colon Cancer Presenting as Status Epilepticus
Presenter:
Date
05/22/2019
Room
Area A (Hall F, Level 2), KBHCCD
Session Name
D49 - CRITICAL CARE CASE REPORTS: NEUROCRITICAL CARE, SEDATION, AND DELIRIUM
Authors
A1660 - A Retrospective Analysis to Estimate the Range of Driving Power
Presenter:
Date
05/19/2019
Room
Area A (Hall F, Level 2), KBHCCD
Session Name
A43 - CRITICAL CARE: MAXIMUM OVERDRIVE - ACUTE RESPIRATORY FAILURE AND MECHANICAL VENTILATION
A7093 - Specific Antibody Response to Seasonal Influenza Vaccine in Chronic Obstructive Pulmonary Disease (COPD) and Healthy Older People
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD
Authors
A3138 - Hemoptysis Due to a Bleeding Bronchial Dieulafoy Lesion Treated Successfully with Arterial Embolization and Argon Plasma Coagulation
Presenter:
Date
05/20/2019
Room
Area C (Hall F, Level 2), KBHCCD
Session Name
B41 - INTERVENTIONAL PULMONOLOGY CASE REPORTS I
Authors
A2465 - Phenotypic Clusters Derived from Clinical Notes of Patients with Respiratory Failure
Presenter:
Date
05/19/2019
Room
Dallas Ballroom E-F (Level 3), Omni Dallas Downtown
Session Name
A103 - CRITICAL CARE: AS YOU LIKE IT - ICU MANAGEMENT AND PROCESSES OF CARE
Authors
A1609 - Early Experience with Heated Humidified High-Flow Oxygen Therapy for Acute Respiratory Failure in Adults
Presenter:
Date
05/19/2019
Room
Area A (Hall F, Level 2), KBHCCD
Session Name
A42 - CRITICAL CARE: WHERE THE SIDEWALK ENDS - NONCONVENTIONAL VENTILATION, HFNC, NIV AND ECMO
Authors
A5627 - Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib
Presenter:
Date
05/21/2019
Room
Room C140/C142 (Level 1), KBHCCD
Session Name
C101 - NON-IDIOPATHIC INTERSTITIAL PNEUMONIA NATURAL HISTORY AND PROGNOSIS AND ILD THERAPY
A6323 - Erdheim-Chester Disease Presenting with Spontaneous Pneumothorax
Presenter:
Date
05/22/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
D39 - RARE DPLD CASE REPORTS
Authors
A7393 - Mortality Effect of the Anti-Fibrotics Pirfenidone and Nintedanib in Clinical Practice
Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C35 - HEALTH SERVICES RESEARCH IN COUGH, CF, AND ILD
Authors
A5248 - MEK/ERK Inhibitors Affect Epithelial Barrier Function in Cells with Ongoing Active Repair Processes Indicating a Potential Hazard in Patients with Healing Lung
Presenter:
Date
05/21/2019
Room
Area C (Hall F, Level 2), KBHCCD
Session Name
C58 - MECHANISMS OF PULMONARY FIBROSIS